Article
Publicly Available
Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogens
-
Thomas Strecker
Published/Copyright:
May 23, 2012
Received: 2011-10-12
Accepted: 2012-04-22
Published Online: 2012-05-23
Published in Print: 2012-07-01
©2012 by Walter de Gruyter Berlin Boston
Articles in the same Issue
- Masthead
- Masthead
- Editorial
- Fit for Future – Help Healing the World: IFCC-WorldLab in Berlin 2011
- Reviews
- European medical laboratory accreditation. Present situation and steps to harmonisation
- Quality assurance and quality control in the routine molecular diagnostic laboratory for infectious diseases
- Translating exome sequencing from research to clinical diagnostics
- Laboratory approaches for predicting and managing the risk of cardiovascular disease: postanalytical opportunities of lipid and lipoprotein testing
- Pregnancy-associated plasma protein A: spotlight on kidney diseases
- Measurement of factor XIII activity in plasma
- Update on multiple sclerosis, its diagnosis and treatments
- Recommendations on prenatal screening and the connections to other diseases such as thyroid dysfunction
- Mini Reviews
- Experience of Médecins Sans Frontières in laboratory medicine in resource-limited settings
- Highlights in inflammatory bowel disease – from bench to bedside
- Opinion Papers
- Implementation of standardization in clinical practice: not always an easy task
- IFCC standardised HbA1c: should the world be as one?
- Reflective testing: adding value to laboratory testing
- Original Articles
- Low angle light scattering analysis: a novel quantitative method for functional characterization of human and murine platelet receptors
- The recoveryELISA – a newly developed immunoassay for measurement of therapeutic antibodies and the target antigen during antibody therapy
- Implementation of new recommendations for the diagnosis of gestational diabetes: a 5-month audit
- Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogens
Keywords for this article
influenza A virus;
influenza vaccine development;
pandemic;
reassortment;
reverse genetics
Articles in the same Issue
- Masthead
- Masthead
- Editorial
- Fit for Future – Help Healing the World: IFCC-WorldLab in Berlin 2011
- Reviews
- European medical laboratory accreditation. Present situation and steps to harmonisation
- Quality assurance and quality control in the routine molecular diagnostic laboratory for infectious diseases
- Translating exome sequencing from research to clinical diagnostics
- Laboratory approaches for predicting and managing the risk of cardiovascular disease: postanalytical opportunities of lipid and lipoprotein testing
- Pregnancy-associated plasma protein A: spotlight on kidney diseases
- Measurement of factor XIII activity in plasma
- Update on multiple sclerosis, its diagnosis and treatments
- Recommendations on prenatal screening and the connections to other diseases such as thyroid dysfunction
- Mini Reviews
- Experience of Médecins Sans Frontières in laboratory medicine in resource-limited settings
- Highlights in inflammatory bowel disease – from bench to bedside
- Opinion Papers
- Implementation of standardization in clinical practice: not always an easy task
- IFCC standardised HbA1c: should the world be as one?
- Reflective testing: adding value to laboratory testing
- Original Articles
- Low angle light scattering analysis: a novel quantitative method for functional characterization of human and murine platelet receptors
- The recoveryELISA – a newly developed immunoassay for measurement of therapeutic antibodies and the target antigen during antibody therapy
- Implementation of new recommendations for the diagnosis of gestational diabetes: a 5-month audit
- Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogens